These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 6111984)

  • 21. Comparison of the antiarrhythmic activity of quinidine and quinine.
    Klevans LR; Kelly RJ; Kovacs JL
    Arch Int Pharmacodyn Ther; 1977 May; 227(1):57-68. PubMed ID: 901074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiarrhythmic and antifibrillatory actions of the levo- and dextrorotatory isomers of sotalol.
    Lynch JJ; Wilber DJ; Montgomery DG; Hsieh TM; Patterson E; Lucchesi BR
    J Cardiovasc Pharmacol; 1984; 6(6):1132-41. PubMed ID: 6084771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effect of some antiarrhythmic drugs in right- or left-sided aconitine-induced experimental atrial arrhythmias.
    Gautam CS; Lal R; Pandhi P; Sharma PL
    Methods Find Exp Clin Pharmacol; 1987 Feb; 9(2):91-3. PubMed ID: 3586773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions of beta-adrenoceptor antagonists and thyroid hormones in the control of heart rate in the dog.
    Allely MC; Ungar A
    Br J Pharmacol; 1985 Oct; 86(2):393-8. PubMed ID: 2864972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative studies in the heart-lung-preparation of dog on the action spectrum of verapamil, quinidine and some alpha- and beta-sympatholytics as well as the effect of adrenaline].
    Haas H; Igarashi T
    Arzneimittelforschung; 1968 Nov; 18(11):1373-80. PubMed ID: 5755900
    [No Abstract]   [Full Text] [Related]  

  • 26. Electrophysiologic and hemodynamic effects of H 234/09 (almokalant), quinidine, and (+)-sotalol in the anesthetized dog.
    Duker G; Almgren O; Carlsson L
    J Cardiovasc Pharmacol; 1992 Sep; 20(3):458-65. PubMed ID: 1279293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ventricular electrophysiology of quinidine-propranolol combinations in the dog heart.
    Korte DW; Nash CB
    J Pharmacol Exp Ther; 1976 May; 197(2):452-7. PubMed ID: 1271287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrophysiological effects of MS-551, a new class III agent: comparison with dl-sotalol in dogs.
    Sen L; Cui G; Sakaguchi Y; Singh BN
    J Pharmacol Exp Ther; 1998 May; 285(2):687-94. PubMed ID: 9580614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modification of ventricular fibrillation thresholds after sympatholytic drugs in the dog.
    Wellens D; Wauters E
    Arch Int Pharmacodyn Ther; 1972 Aug; 198(2):355-71. PubMed ID: 4403391
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of nipradilol (K-351) on the electrophysiological properties of canine cardiac tissues: comparison with propranolol and sotalol.
    Nakaya H; Kimura S; Nakao Y; Kanno M
    Eur J Pharmacol; 1984 Sep; 104(3-4):335-44. PubMed ID: 6149947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sotalol versus class I and II antiarrhythmic agents.
    Hanyok JJ; MacNeil DJ
    Cardiovasc Drugs Ther; 1990 Jun; 4 Suppl 3():603-11. PubMed ID: 2275890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacologic basis of the antiarrhythmic and hemodynamic effects of sotalol.
    Antonaccio MJ; Gomoll A
    Am J Cardiol; 1993 Aug; 72(4):27A-37A. PubMed ID: 8346723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodynamic effects of procainamide and quinidine and the influence of beta-blockade before and after experimental myocardial infarction.
    Côté P; Schook J; Harrison DC; Schroeder JS
    Proc Soc Exp Biol Med; 1975 Sep; 149(4):958-67. PubMed ID: 241083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of some antiarrhythmic drugs on systolic time intervals in normal subjects (author's transl)].
    Breithardt G; Jochum E; Kuhn H; Seipel L
    Z Kardiol; 1978 Oct; 67(10):6,0-7. PubMed ID: 366939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the antifibrillatory activity of fluorinated derivatives of indenolol and nadolol in isolated rabbit and rat hearts: comparison with propranolol.
    Almotrefi AA; Aboul-Enein HY; Premkumar LS
    Arch Int Pharmacodyn Ther; 1989; 301():122-30. PubMed ID: 2576192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiarrhythmic and antifibrillatory actions of the beta adrenergic receptor antagonist, dl-sotalol.
    Patterson E; Lynch JJ; Lucchesi BR
    J Pharmacol Exp Ther; 1984 Aug; 230(2):519-26. PubMed ID: 6086892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha- but not beta-receptor blocking agents inhibit the antiarrhythmic effect of iloprost on ouabain-induced arrhythmia in guinea-pigs.
    Mest HJ; Balewska I
    Biomed Biochim Acta; 1991; 50(7):943-7. PubMed ID: 1722094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of in vivo and in vitro propranolol levels in canine Purkinje fibers with antiarrhythmic effects.
    Pruett JK; Walle T; Bagwell EE
    J Pharmacol Exp Ther; 1977 Jul; 202(1):45-54. PubMed ID: 17729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiarrhythmic effects of four different beta-adrenergic blockers in the mouse chloroform arrhythmia model.
    Reynolds RD; Calzadilla SV
    Res Commun Chem Pathol Pharmacol; 1980 Aug; 29(2):361-4. PubMed ID: 6106265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A cardiac antiarrhythmic screening test using the isolated ischaemic perfused rat heart preparation.
    Lee AY; Zhan CY; Mok CP; Wong TM
    Arch Int Pharmacodyn Ther; 1985 Oct; 277(2):217-22. PubMed ID: 4062438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.